Runben Biotechnology Co., Ltd. (SHA:603193)

Runben Biotechnology Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	1,704	1,545	1,318	1,033	856.09	582.15
Revenue Growth	15.95%	17.19%	27.61%	20.66%	47.06%	31.46%
Gross Profit Gross Profit Growth	1,016	898.19	764.98	579.62	462.81	306.4
Operating Income Operating Income Growth	368.31	327.87	303.08	242.62	177.34	130.58
Net Income Net Income Growth	352.07	314.5	300.16	226.03	160.04	120.65
Earnings Per Share EPS Growth	0.88	0.78	0.74	0.64	0.47	0.36
EPS Growth	15.73%	5.41%	15.63%	36.17%	30.56%	16.13%

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	1,510	1,469	1,434	1,603	376.45	262.43
Total Debt Total Debt Growth	0.7	1.42	2.78	4	7.91	10.31
Net Cash (Debt) Net Cash Growth	1,510	1,467	1,431	1,599	368.54	252.12
Net Cash Growth	6.28%	2.56%	-10.52%	333.90%	46.18%	208.59%
Net Cash Per Share Net Cash Per Share Growth	3.77	3.64	3.53	4.53	1.08	0.75

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	330.45	275.26	257.24	252.52	165.32	138.65
Capital Expenditures CapEx Growth	-81.96	-87.83	-74.22	-13.65	-40.65	-152.03
Free Cash Flow Free Cash Flow Growth	248.49	187.42	183.02	238.87	124.67	-13.38
Free Cash Flow Growth	103.91%	2.41%	-23.38%	91.60%	-	-

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	59.63%	58.14%	58.03%	56.11%	54.06%	52.63%
Operating Margin	21.62%	21.22%	22.99%	23.49%	20.71%	22.43%
Pretax Margin	23.58%	23.45%	26.70%	25.94%	21.99%	24.33%
Profit Margin	20.67%	20.36%	22.77%	21.88%	18.70%	20.72%
FCF Margin	14.59%	12.13%	13.88%	23.13%	14.56%	-2.30%

Dividends

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Aug 25, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
Dividend Per Share Dividend Per Share Growth	0.460	0.460	0.410	0.170
Dividend Per Share Growth	12.20%	12.20%	141.18%	-
Dividend Yield	2.26%	1.92%	1.80%	0.97%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 25, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	23.52	31.17	31.47	32.54	-	-
Forward PE	22.24	24.66	26.27	26.80	-	-
P/FCF Ratio	33.67	52.31	51.62	30.79	-	-
PS Ratio	4.91	6.35	7.17	7.12	-	-

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 25, 2026

Data Sources Report a data error